• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

Advances in Tissue Engineering and Organ Regeneration - Technical Insights Report

  • ID: 2707490
  • August 2013
  • 47 Pages
  • Frost & Sullivan
State-of-the-Art Technology for Artificial Organ Implant

Tissue engineering, which is now being categorized as a form of regenerative medicine, can be defined as biomedical engineering to reconstruct, repair, and improve biological tissues. Research efforts in tissue engineering have been ongoing and it is emerging as one of the key areas of medical research. Furthermore, there are vast developments in tissue engineering, which involve leveraging of technologies from biomaterials, molecular medicine, biochemistry, nanotechnology, genetic and biomedical engineering for regeneration and cell expansion targets to restructure and/or repair human organs.

Tissue engineering is often referred to as regenerative medicine and reparative medicine. It is an interdisciplinary field requiring the combined efforts of cell biologists, engineers, material scientists, geneticists, clinicians, mathematicians etc., towards the development of biological substitutes that restore, maintain, or improve tissue function. Currently it has emerged as a rapidly diversifying field with the potential to address the worldwide organ shortage issue and comprises of tissue regeneration and organ replacement. Cells placed on or within the tissue constructs is the most READ MORE >

Note: Product cover images may vary from those shown
State-of-the-Art Technology for Artificial Organ Implant

1. Executive Summary

2. Technology Snapshot and Trends

- Research Scope
- Research Methodology
- Key Findings

3. Technology Capability

- Technology Value Chain

4. Impact Assessment and Analysis

- Market Impact of Proprietary Technologies

5. Diffusion of Innovations and Needs Assessment

- Business Drivers
- Business Challenges
- Technology Adoption Cycle

6. Opportunity Evaluation and Roadmapping

- Demand Side Analysis
- Scenario Modeling
- Technology Roadmap
- Technology Management Strategies

7. Key Contacts and Patents

8. Decision Support Database

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown


Our Clients

Amgen Inc. Bayer AG Bio-Rad Laboratories, Inc. Beckman Coulter, Inc. Novartis AG Baxter International Inc.